Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
The main question it aims to answer are:
The participants will treated with the custom made semibranch device and enrolled in the registry if they consent. No change in treatment will be made when enrolled.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Semibranch CMD branched aortic stentgraft | Device | bEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design |
| Measure | Description | Time Frame |
|---|---|---|
| Freedom from target vessel instability | primary patency and freedom from stenosis fo the semibranch | 30 days after intervention |
| Mortality | overall mortality rate during 30 days after intervention | 30 days after intervention |
| technical success | Feasibility in terms of cannulation and stentgrafting of the semibranches | During intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Morbidity | Access site, bowel ischemia, kidney failure, paraplegia | During follow up period (up to 3 years) |
| freedom Endoleak Type I and III | absence of endoleaks arising from the semibranch |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with pararenal or thoracoabdominal aortic pathology, who are treated with a endovascular semibranch stentgraft.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alexander Oberhuber, MD,PhD | Contact | +492518345781 | alexander.oberhuber@ukmuenster.de | |
| vascular trial unit | Contact | +492518351717 | vital@ukmuenster.de |
| Name | Affiliation | Role |
|---|---|---|
| Alexander Oberhuber, MD,PhD | Department of Vascular and Endovascular Surgery University Hospital Münster | Study Chair |
| Alexander Oberhuber, MD,PhD | Department of Vascular and Endovascular Surgery University Hospital Münster |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Muenster University Hospital | Recruiting | Münster | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| During follow up period (up to 3 years) |
| Long term mortality | overall mortality up to 3 years | During follow up period (up to 3 years) |
| Branch patency | primary patency of all branches | During follow up period (up to 3 years) |
| ID | Term |
|---|---|
| D001014 | Aortic Aneurysm |
| ID | Term |
|---|---|
| D000783 | Aneurysm |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001018 | Aortic Diseases |
Not provided
Not provided